market analysis

Award, fellowship & grant

Molecules, Mentors & Mindsets

Market Reports

Taltz Biosimilar Landscape: Three Ixekizumab Programs Enter the Race

Market Reports

Will Reblozyl Continue to See the Thinnest Biosimilar Competitive Intensity? | Ounsh Ventures

Market Reports

Enhertu Biosimilars: Is the $15 Billion ADC Market Worth the Risk? | Market Report

Market Reports

Dupixent Biosimilars: $30 Billion Opportunity or High-Risk Investment? | Market Report

Mentor Konnect

Bacteria Adapt to Stress by Balancing Survival and Metabolic Costs

October 15, 2026

DSA3 Targets Thymidine Kinase to Fight Drug-Resistant Staphylococcus aureus

October 14, 2026

IP3R2 Regulates Calcium Signaling to Control Melanosome Degradation

October 14, 2026